FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1157-1173

  Yamazaki, Mayako ^a   Matsuoka, Nobuya ^a   Maeda, Noriaki ^a   Ohkubo, Yoshitaka ^a   Yamaguchi, Isamu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; N (4 ACETYL 1 PIPERAZINYL) 4 FLUOROBENZAMIDE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; DRUG MECHANISM; DRUG SCREENING; MALE; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; BRAIN; CYSTEAMINE; FENCLONINE; MALE; MEMORY; NOOTROPIC AGENTS; OXIDOPAMINE; PIPERAZINES; RAPHE NUCLEI; RATS; RATS, INBRED F344; RECEPTORS, CHOLINERGIC; SEROTONIN; SOMATOSTATIN;

EID: 0030426833     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. ALHAINEN, K., SIRVIÖ, J., HELKALA, E. L., REINIKAINEN, K. AND RIEKKINEN, SR. P.: Somatostatin and cognitive functions in Alzheimer's disease-the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridme. Neurosci. Lett. 130: 46-48, 1991.
2. BAKHIT, C. AND SWERDLOW, N. R.: Behavioral changes following central injection of cysteamine in rats. Brain Res. 365: 159-163, 1986.
3. BARNES, C. A.: Aging and the physiology of spatial memory. Neurobiol. Aging 9: 563-568, 1988.
4. BARTUS, R. T., DEAN, R. L. III, BEER, B. AND LIPPA A. S.: The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417, 1982.
5. BENNETT, G. W., EDWARDSON, J. A., MARCANO DE COTTE, D., BERELOWITZ, M., PIMSTONE, B. L. AND KRONHEIM, S.: Release of somatostatin from rat brain synaptosomes. J. Neurochem. 32: 1127-1130, 1979.
6. BJÖKLUND, A., BAUMGARTEN, H. G. AND RENSCH, A.: 5,7-Dihydroxytryptamine: Improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J. Neurochem. 24: 833-835, 1975.
7. CASSEL, J. C. AND JELTSCH, H.: Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications. Neuroscience 69: 1-41, 1995.
8. COYLE, J. T., PRICE, D. L. AND DELONG, M. R.: Alzheimer's disease: A disorder of cholinergic innervation. Science 219: 1184-1190, 1983.
9. DAVIES, P. AND MALONEY, A. J. F.: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii: 1403, 1976.
10. DAVIES, P., KATZMAN, R. AND TERRY, R. D.: Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288: 279-280, 1980.
11. EPELBAUM, J.: Somatostatin in the central nervous system: Physiology and pathological modifications. Prog. Neurobiil. 27: 63-100, 1986.
12. FONNUM, F.: A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24: 407-409, 1975.
13. GAGE, F. H., BJÖRKLUND, A. AND STENEVI, U.: Intrahippocampal septal grafts ameliorate learning impairments in aged rats. Science 226: 533-536, 1984.
14. GAGE, F. H. AND BJÖRKLUND, A.: Cholinergic septal grafts into the hippocampal formation improve spatial learning and memory in aged rats by an atropine-sensitive mechanism. J. Neurosci. 6: 2837-2847, 1986.
15. GALLAGHER, M. AND PELLEYMOUNTER, M. A.: Spatial learning deficits in old rats: a model for memory decline in the aged. Neurobiol. Aging 9: 549-556, 1988.
16. HAGAN, J. J. AND MORRIS, R. G. M.: The cholinergic hypothesis of memory: a review of animal experiments. In The Handbook of Psychopharmacology, ed. by S. Snyder, L. L. Iversen and S. D. Iversen, vol. 6, pp. 237-323, Plenum Press, New York, 1987.
17. HAROUTUNIAN, V., MANTIN, R., CAMPBELL, G. A., TSUBOYAMA, G. K. AND DAVIES, K. L.: Cysteamine-induced depletion of central somatostatin-like immunoreactivity: Effects on behavior, learning, memory and brain neurochemistry. Brain Res. 403: 234-242, 1987.
18. HAUGER, R. L., THRIVIKRAMAN, K. V. AND PLOTSKY, P. M.: Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Endocrinology 134: 1528-1536, 1994.
19. HEPLER, D. J., WENK, G. L., CRIBBS, B. L., OLTON, D. S. AND COYLE, J. T.: Memory impairments following basal forebrain lesions. Brain Res. 346: 8-14, 1985.
20. ICHIHARA, K., NABESHIMA, T. AND KAMEYAMA, T.: Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol. Biochem. Behav. 30: 107-113, 1988.
21. JOHANSSON, O., HÖKFELT, T. AND ELDE, R. P.: Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 13: 265-339, 1984.
22. KISS, J., CSAKY, A. AND HALASZ, B.: Demonstration of serotonergic axon terminals on somatostatin-immunoreactive neurons of the anterior periventriclar nucleus of the rat hypothalamus. Brain Res. 442: 23-32, 1988.
23. KÖNIG, J. F. R. AND KLIPPEL, R. A.: The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of Brainstem, Williams and Wilkins, Baltimore, 1963.
24. KUBANIS, P. AND ZORNETZER, S. F.: Age-related behavioral and neurobiological changes: a review with an emphasis on memory. Behav. Neural Biol. 31: 115-172, 1981.
25. LIPPA, A. S., PELHAM, R. W., BEER, B., CRITCHETT, D. J., DEAN, R. L. AND BARTUS, R. T.: Brain cholinergic dysfunction and memory in aged rats. Neurobiol. Aging 1: 13-19, 1980.
26. LOWRY, O. H., ROSENBERG, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
27. LUINE, V., BOWLING, D. AND HEARNS, M.: Spatial memory deficits in aged rats: contribution of monoaminergic systems. Brain Res. 537: 271-278, 1990.
28. MAEDA, N., MATSUOKA, N. AND YAMAGUCHI, I.: Septohippocampal cholinergic pathway and penile erection induced by dopaminergic and cholinergic stimulants. Brain Res. 537: 163-168, 1990.
29. MAEDA, N., MATSUOKA, N., YAMAZAKI, M., ARAKAWA, H. OHKUBO, Y. AND YAMAGUCHI, I: A screening concept based on a hypothesis led to the development of a putative cognitive enhancer that stimulates penile erection. Jpn. J. Pharmacol. 64: 147-153, 1994.
30. MAEDA, N., MATSUOKA, N., YAMAZAKI, M. AND YAMAGUCHI, I.: Involvement of raphe-hippocampal serotonergic and septo-hippocampal cholinergic mechanisms in the penile erection induced by FR121196, a putative cognitive enhancer. Jpn. J. Pharmacol. 68: 85-94, 1995.
31. MATSUOKA, N., MAEDA, N., OHKUBO, Y. AND YAMAGUCHI, I.: Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats. Brain Res. 559: 233-240, 1991.
32. MATSUOKA, N., MAEDA, N., YAMAZAKI, M., OHKUBO, Y. AND YAMAGUCHI, I.: Effects of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks. J. Pharmacol. Exp. Ther. 263: 436-444, 1992.
33. MATSUOKA, N., YAMAGUCHI, I. AND SATOH, M.: Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer. Eur. J. Pharmacol. 241: 27-34, 1993.
34. MATSUOKA, N., MAEDA, N., YAMAGUCHI, I. AND SATOH, M.: Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Brain Res. 642: 11-19, 1994.
35. MESULAM, M-M., MUFSON, E. J., WAINER, B. H. AND LEVEY, A. I.: Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10: 1185-1201, 1983.
36. MIYAMOTO, M., KATO, J., NARUMI, S. AND NAGAOKA, A.: Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res. 419: 19-31, 1987.
37. MONDADORI, C: The pharmacology of the nootropics; New insights and new questions. Behav. Brain Res. 59: 1-9, 1993.
38. MUÑOZ-ACEDO, G., LÓPEZ-SAÑUDO, S. AND ARILLA, E.: Reduction of somatostatin receptors in rat hippocampus by treatment with 5,7-dihydroxytryptamine. Neurosci. Lett. 146: 60-64, 1992.
39. NILSSON, O. G., STRECKER, R. E., DASZUTA A. AND BJÖRKLUND, A.: Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat. Brain Res. 453: 235-246, 1988.
40. OHKUBO, Y., NOMURA, K. AND YAMAGUCHI, I: Involvement of dopamine in the mechanism of action of FR64822, a novel non-opioid antinociceptive compound. Eur. J. Pharmacol. 204: 121-125, 1991.
41. PACKARD, M. G. AND WHITE, N. M.: Memory facilitation produced by dopamine agonists: Role of receptor subtype and mnemonic requirements. Pharmacol. Biochem. Behav. 33: 511-518, 1989.
42. PERRY, E. K., TOMLINSON, B. E., BLESSED, G., BERGMANN, K., GIBSON, P. H. AND PERRY, R. H.: Correlation of cholinergic abnormalities with senile plaques and mental scores in senile dementia. Br. Med. J. 2: 1457-1459, 1978.
43. PONZIO, F., CALDERINI, G., LOMUSCIO, G., VANTINI, G., TOFFANO, G. AND ALGERI, S.: Changes in monoamines and their metabolite levels in some brain regions of aged rats. Neurobiol. Aging 3: 23-29, 1982.
44. PRADHAM, S. N.: Central neurotransmitters and aging. Life Sci. 26: 1643-1656, 1980.
45. RICHTER-LEVIN, G. AND SEGAL, M.: Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Res. 477: 404-107, 1989.
46. RIEKKINEN, P. JR., RIEKKINEN, M., SIRVIÖ, J. AND RIEKKINEN, P.: Effects of concurrent nicotine antagonist and PCPA treatments on spatial and passive avoidance learning. Brain Res. 575: 247-250, 1992.
47. RIEKKINEN, P. JR., SIRVIÖ, J. AND RIEKKINEN, P.: Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning. Brain Res. 527: 342-345, 1990a.
48. RIEKKINEN, P. JR., SIRVIÖ, J. AND RIEKKINEN, P.: Similar memory impairments found in medial septo-vertical diagonal band of Broca and nucleus basalis lesioned rats: Are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss? Behav. Brain Res. 37: 81-88, 1990b.
49. SARTER, M., HAGAN, J. AND DUDCHENKO, P.: Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. Psychopharmacol. 107: 144-159, 1992.
50. STECKLER, T. AND SAHGAL, A.: The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav. Brain Res. 67: 165-199, 1995.
51. STEWART, J., MITCHELL, J. AND KALANT, N.: The effects of life-long food restriction on spatial memory in young and aged Fischer 344 rats measured in the eight-arm radial and the Morris water mazes. Neurobiol. Aging 10: 669-675, 1989.
52. STOESSL, A. J., DOURISH, C. T. AND IVERSEN, S. D.: Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: Evidence for mediation by endogenous 5-HT. Brain Res. 517: 111-116, 1990.
53. TERRY, L. C. AND CRAIG, R.: Cysteamine effects on monoamines, dopamine-β-hydroxylase and the hypothalamic-pituitary axis. Neuroendocrinology 41: 467-475, 1985.
54. WANG, Z. P., MAN, S. Y. AND TANG, F.: Age-related changes in the contents of neuropeptides in the rats brain and pituitary. Neurobiol. Aging 14: 529-534, 1993.
55. WENK, H., BIGL, V. AND MEYER, U.: Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats. Brain Res. Rev. 2: 295-316, 1980.
56. YAMAZAKI M., MATSUOKA N., MAEDA N., KURATANI K., OHKUBO Y. AND YAMAGUCHI I.: FR121196, a potential anti-dementia drug, ameliorates the impaired memory of rat in the Morris water maze. J. Pharmacol. Exp. Ther. 272: 256-263, 1995.
57. ZHANG, W. Q., MUNDY, W. R., THAI, L., HUDSON, P. M., GALLAGHER, M., TILSON, H. A. AND HONG, J. S., Decreased glutamate release correlates with elevated dynorphin content in the hippocampus of aged rats with spatial learning deficits. Hippocampus 1: 391-397, 1991.